Analgesic drugs |
Opioids (SQ or transdermal) |
As needed to control symptoms |
Steroids (eg, dexamethasone) |
See below |
Antispasmodic-anticholinergics |
See below |
Antisecretory agents |
Dexamethasone |
6–20 mg/d SQ trial for 3–5 d |
Octreotide |
100–1500 μg/d SQ |
Antispasmodic-anticholinergics |
|
• Hyoscine butylbromide |
40–120 mg/d SQ |
• Glycopyrrolate |
0.1–0.4 mg/d SQ |
• Scopolamine |
0.2–2 mg/d SQ or 1–2 transdermal patches of 1.5 mg every 3 d |
H2-receptor antagonists (eg, famotidine, ranitidine) |
As needed to control symptoms |
Proton pump inhibitors |
As needed to control symptoms |
Antiemetic drugs |
Metoclopramide (if no colicky pain) |
40–240 mg/d SQ |
Haloperidol |
5–15 mg/d SQ |
Olanzapine |
2.5–20 mg/d SL |
Phenothiazines (sedation) |
|
• Chlorpromazine |
50–100 mg rectally or IM every 8 h |
• Prochlorperazine |
25 mg rectally every 8 h |
• Methotrimeprazine |
6.25–50 mg/d SQ |
Dimenhydrinate |
50–100 mg/d SQ, IV, or rectally |
Ondansetron |
4–8 mg twice daily IV |
Other |
Laxative suppositories, enemas |
As needed to control symptoms |
Amidotrizoate7
|
A single 50-mL oral dose with metoclopramide, octreotide, dexamethasone SQ in partial obstruction |